Integrated Wealth Concepts’s ANI Pharmaceuticals ANIP Stock Holding History

Integrated Wealth Concepts’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.7K	Buy	+165	New	+$13.2K	﹤0.01%	4375

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Wealth Concepts's ANIP Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 165 shares worth $13.7K. The stake represents ﹤0.01% of the portfolio and ranks #4375 among its holdings.

307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Integrated Wealth Concepts held 165 shares of ANI Pharmaceuticals worth $13.7K as of Q2 2026.
ANI Pharmaceuticals was a new Integrated Wealth Concepts position in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4375 holding.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.